Novavax, Inc. (NVAX) vs Zenas BioPharma, Inc. (ZBIO)
Novavax, Inc. and Zenas BioPharma, Inc. are both Biotechnology companies. Novavax, Inc. and Zenas BioPharma, Inc. are of similar size ($1.8B and $1.8B). Zenas BioPharma, Inc. has the higher net margin (0.00% vs −59.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Novavax, Inc. leads on 7 and Zenas BioPharma, Inc. on 4.
Valuation
Profitability
| Metric | NVAX | ZBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.60% | — | 65.16% |
| Operating margin | (56.58%) | 0.00% | 0.00% |
| Net margin | (59.87%) | 0.00% | 0.00% |
| Free cash flow margin | (10.20%) | 0.00% | 0.00% |
| Return on equity | 323.66% | (199.04%) | (57.72%) |
| Return on assets | (21.62%) | (97.39%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack